Brief: Halozyme Withdraws Proposal To Acquire Evotec Following Evotec's Unwillingness To Engage In Discussions

Halozyme Therapeutics

22/11/2024 13:53

Nov 22 (Reuters) - Halozyme Therapeutics Inc  HALO.O :
    * HALOZYME WITHDRAWS PROPOSAL TO ACQUIRE EVOTEC FOLLOWING
EVOTEC'S
UNWILLINGNESS TO ENGAGE IN DISCUSSIONS
    * REITERATE RAISED 2024 GUIDANCE FOR REVENUE OF $970-$1,020
MILLION AND ADJUSTED EBITDA OF $595-$625 MILLION
    * TO DATE, EVOTEC HAS BEEN UNWILLING TO ENGAGE WITH US TO
EXPLORE
A POTENTIAL COMBINATION AND A COMPANY SPOKESPERSON HAS PUBLICLY
COMMENTED THAT ITS GOAL IS TO REMAIN AN INDEPENDENT COMPANY

Source text:  ID:nPn4cwbXMa 
Further company coverage:  EVTG.DE 

 (Gdansk Newsroom)
 (((( gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))